TY - JOUR
T1 - Concentration of non-steroidal anti-inflammatory drugs in the pelvic floor muscles
T2 - An experimental comparative rat model
AU - Chin, Hung Yen
AU - Changchien, Eileen
AU - Lin, Mei Fung
AU - Chiang, Chi Hsin
AU - Wang, Chin Jung
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Purpose: The aim of this study is to explore non-steroid anti-inflammation drugs (NSAIDs) potency for pelvic floor muscle pain by measuring local concentration in a rat model. Materials and Methods: We used nine NSAIDs, including nabumetone, naproxen, ibuprofen, meloxicam, piroxicam, diclofenac potassium, etodolac, indomethacin, and sulindac, and 9 groups of female Wister rats. Each group of rats was fed with one kind of NSAID (2 mg/mL) for three consecutive days. Thereafter, one mL of blood and one gram of pelvic floor muscle were taken to measure drug pharmacokinetics, including partition coefficient, lipophilicity, elimination of half-life (T1/2) and muscle/plasma converting ratio (Css, muscle/Css, plasma). Results: Diclofenac potassium had the lowest T1/2 and the highest mean Css, muscle/Css, plasma (1.9 hours and 0.85±0.53, respectively). The mean Css, muscle/Css, plasma of sulindac, naproxen and ibuprofen were lower than other experimental NSAIDs. Conclusion: Diclofenac potassium had the highest disposition in pelvic floor muscle in a rat model. The finding implies that diclofenac potassium might be the choice for pain relief in pelvic muscle.
AB - Purpose: The aim of this study is to explore non-steroid anti-inflammation drugs (NSAIDs) potency for pelvic floor muscle pain by measuring local concentration in a rat model. Materials and Methods: We used nine NSAIDs, including nabumetone, naproxen, ibuprofen, meloxicam, piroxicam, diclofenac potassium, etodolac, indomethacin, and sulindac, and 9 groups of female Wister rats. Each group of rats was fed with one kind of NSAID (2 mg/mL) for three consecutive days. Thereafter, one mL of blood and one gram of pelvic floor muscle were taken to measure drug pharmacokinetics, including partition coefficient, lipophilicity, elimination of half-life (T1/2) and muscle/plasma converting ratio (Css, muscle/Css, plasma). Results: Diclofenac potassium had the lowest T1/2 and the highest mean Css, muscle/Css, plasma (1.9 hours and 0.85±0.53, respectively). The mean Css, muscle/Css, plasma of sulindac, naproxen and ibuprofen were lower than other experimental NSAIDs. Conclusion: Diclofenac potassium had the highest disposition in pelvic floor muscle in a rat model. The finding implies that diclofenac potassium might be the choice for pain relief in pelvic muscle.
KW - Chronic pelvic pain
KW - Myofacial pain syndrome
KW - Non-steroid anti-inflammation drugs
KW - Pelvic floor muscle
KW - Chronic pelvic pain
KW - Myofacial pain syndrome
KW - Non-steroid anti-inflammation drugs
KW - Pelvic floor muscle
UR - http://www.scopus.com/inward/record.url?scp=84903188466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903188466&partnerID=8YFLogxK
U2 - 10.3349/ymj.2014.55.4.1095
DO - 10.3349/ymj.2014.55.4.1095
M3 - Article
C2 - 24954342
AN - SCOPUS:84903188466
SN - 0513-5796
VL - 55
SP - 1095
EP - 1100
JO - Yonsei Medical Journal
JF - Yonsei Medical Journal
IS - 4
ER -